MENU

LBRX LB Pharmaceuticals Inc Forecast, Technical & Fundamental Analysis

LB Pharmaceuticals Inc is a late-stage biopharmaceutical company developing novel therapies for the treatment of a wide range of neuropsychiatric disorders including schizophrenia, bipolar depression, adjunctive treatment of depressive disorder and other diseases... Show more

LBRX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
LBRX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

LBRX is expected to report earnings to rise 47.76% to -99 cents per share on November 05

LB Pharmaceuticals Inc LBRX Stock Earnings Reports
Q3'26
Est.
$-0.99
Q1'26
Missed
by $0.17
Q4'25
Beat
by $0.13
The last earnings report on May 12 showed earnings per share of -67 cents, missing the estimate of -50 cents. With 84.17K shares outstanding, the current market capitalization sits at 1.44B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
One Pennsylvania Plaza
Phone
+1 212 605-0300
Employees
27
Web
https://www.lbpharma.us
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ROE43.320.59
+1.37%
Astoria US Equal Weight Quality KingsETF
STXF49.390.39
+0.80%
Strive 500 ETF
TESL13.970.09
+0.62%
Simplify Volt TSLA Revolution ETF
KDEC28.590.10
+0.35%
Innovator U.S. Small Cp Pwr Buf ETF -Dec
DLFE32.370.08
+0.25%
FT Vest U.S. Equity Dual Directional Buffer ETF - February
LB Pharmaceuticals (LBRX) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com